Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP592114.RAkTVxMLm3okL_dM4RkrQcIzMsns6DfdL-aWC1nS7TarM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP592114.RAkTVxMLm3okL_dM4RkrQcIzMsns6DfdL-aWC1nS7TarM130_assertion type Assertion NP592114.RAkTVxMLm3okL_dM4RkrQcIzMsns6DfdL-aWC1nS7TarM130_head.
- NP592114.RAkTVxMLm3okL_dM4RkrQcIzMsns6DfdL-aWC1nS7TarM130_assertion description "[This study was conducted to test the efficacy of a new cancer vaccine, composed of dendritic cells (DCs) pulsed with an interleukin-2 gene-encoded vaccinia virus tumor oncolysate (DC-IL-2VCO) in a CC-36 murine colon adenocarcinoma model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP592114.RAkTVxMLm3okL_dM4RkrQcIzMsns6DfdL-aWC1nS7TarM130_provenance.
- NP592114.RAkTVxMLm3okL_dM4RkrQcIzMsns6DfdL-aWC1nS7TarM130_assertion evidence source_evidence_literature NP592114.RAkTVxMLm3okL_dM4RkrQcIzMsns6DfdL-aWC1nS7TarM130_provenance.
- NP592114.RAkTVxMLm3okL_dM4RkrQcIzMsns6DfdL-aWC1nS7TarM130_assertion SIO_000772 17275030 NP592114.RAkTVxMLm3okL_dM4RkrQcIzMsns6DfdL-aWC1nS7TarM130_provenance.
- NP592114.RAkTVxMLm3okL_dM4RkrQcIzMsns6DfdL-aWC1nS7TarM130_assertion wasDerivedFrom befree-2016 NP592114.RAkTVxMLm3okL_dM4RkrQcIzMsns6DfdL-aWC1nS7TarM130_provenance.
- NP592114.RAkTVxMLm3okL_dM4RkrQcIzMsns6DfdL-aWC1nS7TarM130_assertion wasGeneratedBy ECO_0000203 NP592114.RAkTVxMLm3okL_dM4RkrQcIzMsns6DfdL-aWC1nS7TarM130_provenance.